Mark Colonnese, Paul Kinnon, Leon Richards

Nov 10, 2014

Transgenomic said this week that Mark Colonnese has resigned as CFO and executive vice president, effective Oct. 30, 2014. Transgenomics President and CEO Paul Kinnon will assume the role of interim CFO.

Additionally, Leon Richards, Transgenomic's corporate controller, will take on additional responsibilities as chief accounting officer. Richards joined the financial group at Transgenomic in 2012. Previously, he served as corporate controller and chief accounting officer at Baldwin Technology Company. Earlier in his career he was director of financial reporting and control at Ciba Specialty Chemicals (now BASF), and he also held positions of increasing responsibility in the financial group at Hercules (now Ashland Chemical).

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.